A Trial Comparing the Pharmacokinetic Properties of FIAsp After Different Injection Regions and Routes of Administration in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 21 Feb 2017
Price : $35 *
At a glance
- Drugs Insulin aspart (Primary) ; Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 10 Feb 2017 Results assessing the pharmacokinetics published in the Clinical Drug Investigation.
- 11 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Mar 2014 New trial record